The Impact of Graft-versus-Host Disease (GVHD)
Graft-versus-Host Disease (GVHD) is a major challenge in the bone marrow transplant Market, particularly in allogeneic transplants. GVHD occurs when the donor's T-cells recognize the recipient's body as foreign and attack it, leading to widespread tissue damage. This can be a life-threatening complication that significantly increases patient morbidity and mortality.
The management of GVHD is a key area of research and development. The market is seeing the emergence of new prophylactic treatments and immunosuppressive therapies designed to prevent or mitigate the effects of GVHD. The focus on reducing this risk is a major factor driving innovation and shaping the development of new BMT protocols.
3 Views